Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24

International Immunopharmacology

Volumn 29, Issue 2, 2015, Pages 416-422

  Han, Zhengquan ^a   Zhu, Shengming ^b   Han, Xiao ^a   Wang, Zian ^a   Wu, Shiwu ^a   Zheng, Rongsheng ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Apoptosis; Baicalein; CD24; Hepatocellular carcinoma; Inhibition

Indexed keywords

ALOIN; ASTRAGALOSIDE; BAICALEIN; CD24 ANTIGEN; DAPHNIN; EPHEDRA SINICA STAPF; ESCULIN; GENIPIN; GENIPOSIDE; HONOKIOL; MESSENGER RNA; MYC PROTEIN; NUCIFERINE; OROBANCHE PYCNOSTACHYA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FLAVANONE DERIVATIVE; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG MECHANISM; EPHEDRA SINICA; GENETIC TRANSFECTION; HEPATOCELLULAR CARCINOMA CELL LINE; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; PLASMID; SCUTELLARIA BAICALENSIS; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD24; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; FLAVANONES; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS; PLASMIDS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SCUTELLARIA BAICALENSIS;

EID: 84948453778     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.10.021     Document Type: Article

References (30)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
3. J. Zheng, Y. Li, J. Yang, Q. Liu, M. Shi, R. Zhang, and et al. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression BMC Cancer 11 251 2011 1 9
4. X. He, Z. Wei, E. Zhou, L. Chen, J. Kou, J. Wang, and et al. Baicalein attenuates inflammatory responses by suppressing TLR4 mediated NF-kappaB and MAPK signaling pathways in LPS-induced mastitis in mice Int. Immunopharmacol. 28 2015 470 476
5. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang Flavonoids: promising anticancer agents Med. Res. Rev. 23 2003 519 534
6. Y.H. Zheng, L.H. Yin, T.H. Grahn, A.F. Ye, Y.R. Zhao, and Q.Y. Zhang Anticancer effects of baicalein on hepatocellular carcinoma cells Phytother. Res. 28 2014 1342 1348
7. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat. Genet. 31 2002 339 346
8. C.M. Shachaf, A.M. Kopelman, C. Arvanitis, A. Karlsson, S. Beer, S. Mandl, and et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer Nature 431 2004 1112 1117
9. C. Arvanitis, and D.W. Felsher Conditional transgenic models define how MYC initiates and maintains tumorigenesis Semin. Cancer Biol. 16 2006 313 317
10. D. Ruggero The role of Myc-induced protein synthesis in cancer Cancer Res. 69 2009 8839 8843
11. G. Kristiansen, M. Sammar, and P. Altevogt Tumour biological aspects of CD24, a mucin-like adhesion molecule J. Mol. Histol. 35 2004 255 262
12. X.R. Yang, Y. Xu, B. Yu, J. Zhou, J.C. Li, S.J. Qiu, and et al. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clin. Cancer Res. 15 2009 5518 5527
13. B. Li, Q. Shao, D. Ji, F. Li, X. Guo, and G. Chen Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma Diagn. Pathol. 9 2014 209
14. R. Chen, D. Zhu, X. Ye, D. Shen, and R. Lu Establishment of three human liver carcinoma cell lines and some of their biological characteristics in vitro Sci. Sinica 23 1980 236 247
15. K. Shchors, and G. Evan Tumor angiogenesis: cause or consequence of cancer? Cancer Res. 67 2007 7059 7061
16. D.S. Chou, G. Hsiao, Y.A. Lai, Y.J. Tsai, and J.R. Sheu Baicalein induces proliferation inhibition in B16F10 melanoma cells by generating reactive oxygen species via 12-lipoxygenase Free Radic. Biol. Med. 46 2009 1197 1203
17. H.M. Kuo, H.C. Tsai, Y.L. Lin, J.S. Yang, A.C. Huang, M.D. Yang, and et al. Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells Int. J. Oncol. 35 2009 717 724
18. Y. Motoo, and N. Sawabu Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines Cancer Lett. 86 1994 91 95
19. M. Li-Weber New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin Cancer Treat. Rev. 35 2009 57 68
20. G. Donald, K. Hertzer, and G. Eibl Baicalein - an intriguing therapeutic phytochemical in pancreatic cancer Curr. Drug Targets 13 2012 1772 1776
21. H. Takahashi, M.C. Chen, H. Pham, E. Angst, J.C. King, J. Park, and et al. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells Biochim. Biophys. Acta 2011 1813 1465 1474
22. Y. Peng, C. Guo, Y. Yang, F. Li, Y. Zhang, B. Jiang, and et al. Baicalein induces apoptosis of human cervical cancer HeLa cells in vitro Mol. Med. Rep. 11 2015 2129 2134
23. P. Aryal, K. Kim, P.H. Park, S. Ham, J. Cho, and K. Song Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells FEBS J. 281 2014 4644 4658
24. J. Friederichs, Y. Zeller, A. Hafezi-Moghadam, H.J. Grone, K. Ley, and P. Altevogt The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells Cancer Res. 60 2000 6714 6722
25. S. Aigner, Z.M. Sthoeger, M. Fogel, E. Weber, J. Zarn, M. Ruppert, and et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells Blood 89 1997 3385 3395
26. E. Sagiv, A. Starr, U. Rozovski, R. Khosravi, P. Altevogt, T. Wang, and et al. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA Cancer Res. 68 2008 2803 2812
27. T.K. Lee, A. Castilho, V.C. Cheung, K.H. Tang, S. Ma, and I.O. Ng CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation Cell Stem Cell 9 2011 50 63
28. P. Baumann, N. Cremers, F. Kroese, G. Orend, R. Chiquet-Ehrismann, T. Uede, and et al. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis Cancer Res. 65 2005 10783 10793
29. S.C. Smith, G. Oxford, Z. Wu, M.D. Nitz, M. Conaway, H.F. Frierson, and et al. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer Cancer Res. 66 2006 1917 1922
30. M. Hosonaga, Y. Arima, E. Sugihara, N. Kohno, and H. Saya Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells Cancer Sci. 105 2014 779 787